130 related articles for article (PubMed ID: 24755277)
41. Single nucleotide polymorphisms within interferon signaling pathway genes are associated with colorectal cancer susceptibility and survival.
Lu S; Pardini B; Cheng B; Naccarati A; Huhn S; Vymetalkova V; Vodickova L; Buchler T; Hemminki K; Vodicka P; Försti A
PLoS One; 2014; 9(10):e111061. PubMed ID: 25350395
[TBL] [Abstract][Full Text] [Related]
42. Genetic variations in the HIF1A gene modulate response to adjuvant chemotherapy after surgery in patients with colorectal cancer.
Zhang Y; Wang P; Zhou XC; Bao GQ; Lyu ZM; Liu XN; Wan SG; He XL; Huang QC
Asian Pac J Cancer Prev; 2014; 15(11):4637-42. PubMed ID: 24969897
[TBL] [Abstract][Full Text] [Related]
43. Association analysis of miRNA-related genetic polymorphisms in miR-143/145 and KRAS with colorectal cancer susceptibility and survival.
Wang D; Liu Q; Ren Y; Zhang Y; Wang X; Liu B
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33825830
[TBL] [Abstract][Full Text] [Related]
44. Impact of Genetic Variation in MicroRNA-binding Site on Susceptibility to Colorectal Cancer.
Kang BW; Jeon HS; Chae YS; Lee SJ; Park JS; Choi GS; Kim JG
Anticancer Res; 2016 Jul; 36(7):3353-61. PubMed ID: 27354594
[TBL] [Abstract][Full Text] [Related]
45. Polymorphisms in microRNA genes as predictors of clinical outcomes in colorectal cancer patients.
Pardini B; Rosa F; Naccarati A; Vymetalkova V; Ye Y; Wu X; di Gaetano C; Buchler T; Novotny J; Matullo G; Vodicka P
Carcinogenesis; 2015 Jan; 36(1):82-6. PubMed ID: 25368035
[TBL] [Abstract][Full Text] [Related]
46. GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer.
Liu X; Jiang B; Wang A; Di J; Wang Z; Chen L; Su X
PLoS One; 2015; 10(8):e0136020. PubMed ID: 26287967
[TBL] [Abstract][Full Text] [Related]
47. Polymorphisms in Non-coding RNA Genes and Their Targets Sites as Risk Factors of Sporadic Colorectal Cancer.
Vodicka P; Pardini B; Vymetalkova V; Naccarati A
Adv Exp Med Biol; 2016; 937():123-49. PubMed ID: 27573898
[TBL] [Abstract][Full Text] [Related]
48. Mismatch repair status and synchronous metastases in colorectal cancer: A nationwide cohort study.
Nordholm-Carstensen A; Krarup PM; Morton D; Harling H;
Int J Cancer; 2015 Nov; 137(9):2139-48. PubMed ID: 25921209
[TBL] [Abstract][Full Text] [Related]
49. Dietary methyl donor nutrients, DNA mismatch repair polymorphisms, and risk of colorectal cancer based on microsatellite instability status.
Kim J; Lee J; Oh JH; Sohn DK; Shin A; Kim J; Chang HJ
Eur J Nutr; 2022 Sep; 61(6):3051-3066. PubMed ID: 35353199
[TBL] [Abstract][Full Text] [Related]
50. The Effect of
Alhadheq AM; Purusottapatnam Shaik J; Alamri A; Aljebreen AM; Alharbi O; Almadi MA; Alhadeq F; Azzam NA; Semlali A; Alanazi M; Bazzi MD; Reddy Parine N
Dis Markers; 2016; 2016():8289293. PubMed ID: 27746584
[No Abstract] [Full Text] [Related]
51. Association of DNA repair gene polymorphisms with colorectal cancer risk and treatment outcomes.
Al-Shaheri FN; Al-Shami KM; Gamal EH; Mahasneh AA; Ayoub NM
Exp Mol Pathol; 2020 Apr; 113():104364. PubMed ID: 31881200
[TBL] [Abstract][Full Text] [Related]
52. Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study.
Conde J; Silva SN; Azevedo AP; Teixeira V; Pina JE; Rueff J; Gaspar JF
BMC Cancer; 2009 Sep; 9():344. PubMed ID: 19781088
[TBL] [Abstract][Full Text] [Related]
53. A subset of genetic susceptibility variants for colorectal cancer also has prognostic value.
Noci S; Dugo M; Bertola F; Melotti F; Vannelli A; Dragani TA; Galvan A
Pharmacogenomics J; 2016 Apr; 16(2):173-9. PubMed ID: 25963333
[TBL] [Abstract][Full Text] [Related]
54. Two variants of Interleukin-1B gene are associated with the decreased risk, clinical features, and better overall survival of colorectal cancer: a two-center case-control study.
Qian H; Zhang D; Bao C
Aging (Albany NY); 2018 Dec; 10(12):4084-4092. PubMed ID: 30563955
[TBL] [Abstract][Full Text] [Related]
55. Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer.
Koessler T; Azzato EM; Perkins B; Macinnis RJ; Greenberg D; Easton DF; Pharoah PD
Int J Cancer; 2009 Apr; 124(8):1887-91. PubMed ID: 19115210
[TBL] [Abstract][Full Text] [Related]
56. Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival.
Lu S; Catalano C; Huhn S; Pardini B; Partu L; Vymetalkova V; Vodickova L; Levy M; Buchler T; Hemminki K; Vodicka P; Försti A
PLoS One; 2019; 14(5):e0216666. PubMed ID: 31091244
[TBL] [Abstract][Full Text] [Related]
57.
Liu X; Yang G; Huang J; Chai L; Liu X; Dai Q; Yang Z
Biomark Med; 2020 Jan; 14(1):13-22. PubMed ID: 31729889
[No Abstract] [Full Text] [Related]
58. Association of the HLA-G 3'UTR polymorphisms with colorectal cancer in Italy: a first insight.
Garziera M; Catamo E; Crovella S; Montico M; Cecchin E; Lonardi S; Mini E; Nobili S; Romanato L; Toffoli G
Int J Immunogenet; 2016 Feb; 43(1):32-9. PubMed ID: 26752414
[TBL] [Abstract][Full Text] [Related]
59. Genetic variations in microRNA-binding sites of solute carrier transporter genes as predictors of clinical outcome in colorectal cancer.
Bendova P; Pardini B; Susova S; Rosendorf J; Levy M; Skrobanek P; Buchler T; Kral J; Liska V; Vodickova L; Landi S; Soucek P; Naccarati A; Vodicka P; Vymetalkova V
Carcinogenesis; 2021 Apr; 42(3):378-394. PubMed ID: 33319241
[TBL] [Abstract][Full Text] [Related]
60. Association of PD-1 and PDL-1 gene polymorphisms with colorectal cancer risk and prognosis.
Cevik M; Namal E; Iner-Koksal U; Dinc-Sener N; Karaalp A; Ciftci C; Susleyici B
Mol Biol Rep; 2022 Mar; 49(3):1827-1836. PubMed ID: 35076848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
